These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Reducing waste: a significant cost containment measure in an i.v. additive program. Coppola PA; Cassidy AP Hosp Pharm; 1987 Dec; 22(12):1215-6, 1246. PubMed ID: 10285376 [TBL] [Abstract][Full Text] [Related]
6. Reducing i.v. waste to under 2.25 percent. Newhouse JG; Paul VM; Waugh NA; Frye CB Hosp Pharm; 1988 Mar; 23(3):241-2, 246-7. PubMed ID: 10312459 [TBL] [Abstract][Full Text] [Related]
7. Automation is prescription for revamping pharmacy services at North Carolina hospital. Health Care Cost Reengineering Rep; 1998 Apr; 3(4):53-6. PubMed ID: 10178978 [TBL] [Abstract][Full Text] [Related]
8. The effect of oral communication on intravenous wastage: talk is cheap. Boomer G; Savoy LB; Marten R Hosp Pharm; 1993 May; 28(5):404-5, 407-9. PubMed ID: 10126024 [TBL] [Abstract][Full Text] [Related]
9. Cost analysis of a satellite pharmacy. Kelly WN; Meyer JD; Flatley CJ Am J Hosp Pharm; 1986 Aug; 43(8):1927-30. PubMed ID: 3092647 [TBL] [Abstract][Full Text] [Related]
10. Determining drug dispensing costs for use in cost-accounting systems. Thielke TS; Charlson JT; Heckethorn D Am J Hosp Pharm; 1988 Apr; 45(4):844-7. PubMed ID: 3376969 [TBL] [Abstract][Full Text] [Related]
11. Justification of a pharmacy intravenous admixture service in an Australian hospital. Plumridge RJ; Maher M Am J Hosp Pharm; 1993 Mar; 50(3):463-6. PubMed ID: 8442462 [TBL] [Abstract][Full Text] [Related]
12. Intravenous admixture service: implementation of service in a complex ICU patient population. Roof PS Hosp Pharm; 1989 Aug; 24(8):633-6, 638. PubMed ID: 10294359 [TBL] [Abstract][Full Text] [Related]
13. Effect on drug costs of implementing decentralized drug distribution. Roberts AW Am J Hosp Pharm; 1983 Apr; 40(4):604-6. PubMed ID: 6846367 [TBL] [Abstract][Full Text] [Related]
14. Recycled unused piggyback admixtures through the use of tamper-proof safety caps. Jennings RH; Schad RF; Kaurich J Hosp Pharm; 1982 Dec; 17(12):643-5, 652. PubMed ID: 10257924 [TBL] [Abstract][Full Text] [Related]
15. Cost analysis of mixing clindamycin and aminoglycosides. Abel SR; Olson SM Am J Hosp Pharm; 1987 Jun; 44(6):1385-7. PubMed ID: 3618617 [TBL] [Abstract][Full Text] [Related]
16. Cost of wastage in a hospital intravenous admixture program. Salberg DJ; Newton RW; Leduc DT Hosp Formul; 1984 May; 19(5):375-8. PubMed ID: 10266241 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of drug distribution costs for controlled versus noncontrolled oral analgesics. Reynolds RC; Ploetz P; Thielke TS Am J Hosp Pharm; 1984 Aug; 41(8):1558-63. PubMed ID: 6475974 [TBL] [Abstract][Full Text] [Related]
18. A cost comparison of intravenous cimetidine delivery systems. Jackson CW; Caldwell RD; Arford PD Hosp Pharm; 1990 Dec; 25(12):1085-9. PubMed ID: 10108250 [TBL] [Abstract][Full Text] [Related]
19. Cost effective and efficient delivery of medications through multi-dose i.v. pumps. Fulmer DB; Chisholm K Can J Hosp Pharm; 1995 Dec; 48(6):356-8. PubMed ID: 10153869 [No Abstract] [Full Text] [Related]
20. Multidisciplinary cost-containment program promoting less frequent administration of injectable mezlocillin. Briceland LL; Nightingale CH; Quintiliani R; Cooper BW Am J Hosp Pharm; 1988 May; 45(5):1082-5. PubMed ID: 3400649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]